We showed that CD-3 activates PP2A by inhibiting CIP2A and produces tumor growth inhibitory effects by promoting dephosphorylation of oncogenic AKT/mTOR signaling proteins in SCSC cells and xenograft tumors in a PP2A-dependent manner. The gene discussed is AKT1; the disease is neoplasm.